Email this article Practical experience in reactor and cyclotron radiopharmaceuticals production at the V.G. Khlopin Radium Institute
- Authors: Kudellin B.K.1
-
Affiliations:
- V.G. Khlopin Radium Institute
- Issue: Vol 3, No 1S (2021): Supplement
- Pages: 46-47
- Section: Пленарное заседание
- URL: https://journals.rcsi.science/PharmForm/article/view/71774
- ID: 71774
Cite item
Abstract
The V.G. Khlopin Radium Institute, one of the oldest Russian research institutes, will celebrate its centenary in 2022. To date, the Institute remains at the forefront of the radiopharmaceuticals production. It provides Saint Petersburg clinics with the necessary substances for diagnosis and treatment on a daily basis. New drugs are being developed: based on 203Pb and 212Pb, as well as 131I.
About the authors
Boris K. Kudellin
V.G. Khlopin Radium Institute
Author for correspondence.
Email: kudelin@khlopin.ru
Head of the Department of Development and Production of Radiopharmaceuticals
Russian Federation, 28, 2nd Murinsky Prospekt, St. Petersburg, 194021References
Supplementary files
